Skip to main navigation Skip to search Skip to main content

Pediatric erythroblastic sarcoma/pure erythroid leukemia with NFIA-CBFA2T3 translocation: Report of two cases, including a case with TP53 mutation, and review of the literature

  • Antonello Cardoni
  • , Evelina Rogges
  • , Sabrina Rossi
  • , Rita De Vito
  • , Emma Rullo
  • , Silvia Vallese
  • , Sabina Barresi
  • , Isabella Giovannoni
  • , Chantal Tancredi
  • , Viola Alesi
  • , Aurore Coulomb
  • , Valeria Ceolin
  • , Francesco Saglio
  • , Marco Leone
  • , Franca Fagioli
  • , Solenne Le Louet
  • , Arnaud Petit
  • , Sabah Boudjemaa
  • , Rita Alaggio

Research output: Contribution to journalArticlepeer-review

Abstract

Pure erythroid leukemia is a rare neoplasm that occurs predominantly in adults, mostly as secondary to cytotoxic chemotherapy and frequently with biallelic TP53 abnormalities. Reports in pediatric patients are even rarer and show neoplasm arising “de novo”, frequent extramedullary sarcomatous presentation and a different molecular profile from the adult counterpart, including frequent gene fusions and no evidence of biallelic TP53 alterations. We describe two cases of pediatric erythroid leukemia / sarcoma with the NFIA::CBFA2T3 fusion, one of which harbored a TP53 mutation, with a review of the literature of pediatric cases with the same fusion and with the analogous NFIA::CBFA2T1 fusion.

Original languageEnglish
Article number300803
JournalHuman Pathology Reports
Volume42
DOIs
Publication statusPublished - Nov 2025
Externally publishedYes

Keywords

  • Erythroid leukemia
  • Erythroid sarcoma
  • NFIA::CBFA2T3
  • Pediatric
  • TP53

Fingerprint

Dive into the research topics of 'Pediatric erythroblastic sarcoma/pure erythroid leukemia with NFIA-CBFA2T3 translocation: Report of two cases, including a case with TP53 mutation, and review of the literature'. Together they form a unique fingerprint.

Cite this